NEW YORK (GenomeWeb News) - Caliper Life Sciences today said second-quarter revenues increased 45 percent as R&D spending grew 35 percent and net loss more than tripled.
 
Total receipts for the three months ended June 30 increased to $35.3 million from $24.3 million year over year.
 
Product sales contributed $21 million, a 71 percent increase year over year; services brought in $8.9 million, a 66 percent increase; and licensing and contracts fell 20 percent to $5.3 million.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.